Showing results (1481-1490 of 2,319) with videos related to
Sort By:
Pageof 232
Expert Opinion on Therapeutic Targets|September 12, 2007
Present and future therapeutic strategies in non-alcoholic fatty liver diseaseGiuseppe Calamita, Piero PortincasaExpert Opinion on Therapeutic Targets|June 3, 2010
Non-cell-autonomous signaling by Shh in tumors: challenges and opportunities for therapeutic targetsMaarten F Bijlsma, Henk RoelinkExpert Opinion on Therapeutic Targets|May 18, 2010
HtrA proteins as targets in therapy of cancer and other diseasesDorota Zurawa-Janicka, Joanna Skorko-Glonek, Barbara LipinskaExpert Opinion on Therapeutic Targets|June 12, 2010
COX-2 expression in human breast carcinomas: correlation with clinicopathological features and prognostic molecular markersAntonella Miglietta, Marina Toselli, Nicoletta Ravarino, et al.Expert Opinion on Therapeutic Targets|June 12, 2010
SHIP2 and its involvement in various diseasesAkira Suwa, Takeshi Kurama, Teruhiko ShimokawaExpert Opinion on Therapeutic Targets|June 12, 2010
Glycobiology of the Leishmania parasite and emerging targets for antileishmanial drug discoverySunandini Chandra, Dipali Ruhela, Anindita Deb, et al.Expert Opinion on Therapeutic Targets|June 5, 2009
A20 is overexpressed in glioma cells and may serve as a potential therapeutic targetQingdong Guo, Hui Dong, Xiaonan Liu, et al.Expert Opinion on Therapeutic Targets|April 27, 2010
Class I histone deacetylases 1, 2 and 3 are highly expressed in classical Hodgkin's lymphomaHeiner Adams, Florian R Fritzsche, Stephan Dirnhofer, et al.Expert Opinion on Therapeutic Targets|May 5, 2009
Glioblastoma multiforme: a review of therapeutic targetsOkezie O Kanu, Ankit Mehta, Chunhui Di, et al.Expert Opinion on Therapeutic Targets|May 17, 2007
Retinoid-related orphan receptor gamma t is a potential therapeutic target for controlling inflammatory autoimmunityZhaofeng Huang, Huimin Xie, Ruiqing Wang, et al.Pageof 232